EVLO (Evelo Biosciences) Other Financing: $4.86 Mil (TTM As of Sep. 2023)


What is Evelo Biosciences Other Financing?

Evelo Biosciences EVLO -99.00% Other Financing is $4.86 Mil as of Sep. 2023.

Evelo Biosciences's Other Financing for the three months ended in Sep. 2023 was $0.00 Mil.

Evelo Biosciences's Other Financing for the trailing twelve months (TTM) ended in Sep. 2023 was $4.86 Mil.

Evelo Biosciences Other Financing Historical Data

* Premium members only.

The historical data trend for Evelo Biosciences's Other Financing can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Evelo Biosciences Other Financing Chart

Evelo Biosciences Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22
Other Financing
Get a 7-Day Free Trial -0.13 0.51 0.47 1.01 0.23

Evelo Biosciences Quarterly Data
Dec18 Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23
Other Financing Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 4.86 0.00 0.00 0.00

Evelo Biosciences Other Financing Calculation

Other Financing represents other cash flow from financing activity that not otherwise classified, which includes:
Proceeds From Stock Option Exercised
Other Financing Charges

Other Financing for the trailing twelve months (TTM) ended in Sep. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was $4.86 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Other Financing →
What does a Other Financing of $4.86 Mil mean?
Evelo Biosciences (EVLO) has a Other Financing of $4.86 Mil as of Sep. 2023. Other Financing represents other cash flow from financing activity that not otherwise classified. View historical data for Evelo Biosciences and its competitors.
Is Evelo Biosciences' Other Financing too high?
Evelo Biosciences' current Other Financing is $4.86 Mil.
How does Evelo Biosciences' Other Financing compare to IMNN and EDSA?
Evelo Biosciences' Other Financing of $4.86 Mil can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Other Financing for a Biotechnology company?
A good Other Financing depends on the Biotechnology industry context. However, Other Financing should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Other Financing mean?
A high Other Financing can signal that a stock is expensive relative to its fundamentals. Other Financing represents other cash flow from financing activity that not otherwise classified. View historical data for Evelo Biosciences and its competitors. Evelo Biosciences's current Other Financing is $4.86 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Evelo Biosciences stock overvalued right now?
Evelo Biosciences (EVLO) has a current Other Financing of $4.86 Mil. The current Other Financing is $4.86 Mil. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Other Financing calculated?
Other Financing is calculated from a company's financial statements. For Evelo Biosciences (EVLO), the current Other Financing is $4.86 Mil as of Sep. 2023. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Evelo Biosciences Business Description

Address 620 Memorial Drive, Cambridge, MA, USA, 02139
Evelo Biosciences Inc is a clinical-stage biotechnology company focused on discovering and developing a new class of oral medicines that act on immune cells in the small intestine with systemic effects. The company is developing EDP1815 as a treatment in psoriasis and atopic dermatitis and EDP2939 in psoriasis.